Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artificial Sensing Instruments (ASI) was a Swiss-based analytical instrumentation company that specialized in high-sensitivity biosensor systems. The company is primarily recognized for developing Optical Waveguide Lightmode Spectroscopy (OWLS), a label-free technology used to monitor molecular interactions in real-time. ASI's instruments allowed researchers to study protein adsorption, lipid bilayer formation, and cell adhesion with extreme precision. Founded as a spin-off from ETH Zurich, the company played a significant role in the advancement of surface science within the life sciences sector. While ASI AG is no longer active, its core OWLS technology was transitioned to MicroVacuum Ltd, which continues to provide these analytical solutions to the global research community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artificial Sensing Instruments.